author-photo

Yingxin Zhang

Pfizer

8

Papers

138

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Evolution of the Synthesis of AMPK Activators for the Treatment of Diabetic Nephropathy: From Three Preclinical Candidates to the Investigational New Drug PF-06409577

2018 Organic Process Research & Development
Show All
- Source
- Cite
- Save
Citations (9)
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate

2014 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (35)
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity.

2010 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (23)